Twenty years of innovation, but a vision that remains unchanged. Valued for the standardized collection and analysis of tissue samples that has enabled a truly unique multi-omics database, we are on the verge of reshaping what is possible in the field of precision oncology. We have unlocked an understanding of the molecular reality of cancer at an unparalleled level that is now supporting biomarker and target discovery and validation, drug development, and clinical trial performance. We continue striving for a world where precision therapy is possible for each individual cancer patient. To learn more about our mission, visit www.indivumed-therapeutics.com.

Life Sciences

Therapeutics

Indivumed Therapeutics

Prof. Dr. Hartmut Juhl

Andrea Meyer

Martin Heuseler

Jonathan Woodsmith

Kristin Maack

Angie Reichard

Nina Gabelia

Katharina Krohn

Nils John Schumacher

Leonidas Leondaridis

Jobst Landgrebe

Leadership Team

Clinical Operations and Research

Finance and Administration

Data and Software Development

Sales and Marketing

Teams at Indivumed Therapeutics

Leadership Team

Clinical Operations and Research

Finance and Administration

Data and Software Development

Sales and Marketing